Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
Marinus Pharmaceuticals (Nasdaq: MRNS) announced its participation in two key investor conferences this September. The company will present at the Baird 2022 Global Healthcare Conference in New York on September 13 at 2:35 p.m. ET, and at the H.C. Wainwright 24th Annual Global Investment Conference on September 14 at 12:00 p.m. ET. Interested parties can access event links on the company’s Investors & Media page. A replay of the presentations will be available shortly after each event.
- None.
- None.
-
Baird 2022 Global Healthcare Conference (
New York, NY ) onTuesday, September 13 at2:35 p.m. ET . This event is closed to conference participants only. -
H.C. Wainwright 24th AnnualGlobal Investment Conference (New York, NY ) onWednesday, September 14 at12:00 p.m. ET .
Links to each event can be accessed on the Investors & Media page of Marinus’ website at ir.marinuspharma.com/events-and-presentations. A replay of the webcasts will be available approximately two hours after the completion of the events and will be archived for up to 90 days.
About
Marinus is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. The Company’s commercial product, ZTALMY® (ganaxolone) oral suspension CV, has been approved by the
View source version on businesswire.com: https://www.businesswire.com/news/home/20220907005431/en/
Company
Vice President, Corporate Affairs & Investor Relations
sdamouni@marinuspharma.com
Source:
FAQ
What conferences will Marinus Pharmaceuticals participate in September 2022?
What date and time will Marinus Pharmaceuticals present at the Baird Conference?
When is the H.C. Wainwright Conference for Marinus Pharmaceuticals?
Where can I find the links to Marinus Pharmaceuticals' investor conference presentations?